Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Equities research analysts at Leerink Partnrs raised their Q3 2023 earnings per share (EPS) estimates for Solid Biosciences in a research note issued to investors on Wednesday, August 16th. Leerink Partnrs analyst J. Schwartz now expects that the company will post earnings of ($1.05) per share for […]
Related Keywords
United States , Leerink Partnrs , Solid Biosciences Inc , Vanguard Group Inc , Renaissance Technologies , Nasdaq , Solid Biosciences Company Profile , Alyeska Investment Group , Millennium Management , Solid Biosciences , Free Report , Solid Bioscience , Street Corp , Get Free Report , Biosciences Inc , Solid Biosciences Daily , Nasdaq Sldb , Sldb , Medical , Earnings Estimates ,
vimarsana.com © 2020. All Rights Reserved.